Business Analyst, Revenue Cycle Operations at Natera

United States

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Medical DevicesIndustries

Requirements

Candidates should possess a Bachelor’s degree in Business, Economics, Healthcare Administration, Information Systems, or a related field, or equivalent experience, and a minimum of 3 years of experience in healthcare revenue cycle analytics, insurance billing, or claims reimbursement. A deep understanding of the claim life cycle, payer reimbursement models, and insurance billing workflows is essential.

Responsibilities

The Business Analyst will analyze billing, claims, and payment data to identify trends in payer reimbursement, claim denials, and rejections, develop reports, dashboards, and visualizations using SQL and BI tools, conduct data extractions and reconciliations, partner with Finance, Insurance Billing, Market Access, and Product teams to provide insights, support payer contract compliance analysis, work closely with IT and Data Engineering, identify opportunities for process improvements in claims submission, payer compliance, and denial resolution, design and implement workflow enhancements, ensure adherence to HIPAA and regulatory requirements, and respond to ad hoc data requests from leadership and key stakeholders.

Skills

SQL

Business Intelligence Tools

Power BI

Tableau

Data Analysis

Billing

Claims Processing

Reimbursement Analytics

Data Visualization

Dashboard Development

Reporting

Data Extraction

Data Reconciliation

Payer Contracts

Healthcare Revenue Cycle Management

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free